Related Experiment Videos
DC-86-M, a novel antitumor antibiotic. I. Taxonomy of producing organism and fermentation
Abstract:
A novel antibiotic, DC-86-M was isolated from the culture broth of a new isolate, DO-86, from the soil sample collected in Machida-shi, Japan. The producing organism was found to belong to Streptomycetes, for it formed aerial mycelia and chains of spores and its cell wall analyses revealed the presence of LL-diaminopimelic acid. The morphological, cultural and physiological characteristics of the strain DO-86 resemble closely those of Streptomyces luteogriseus and we concluded that the strain DO-86 could be designated as Streptomyces luteogriseus DO-86. The antibiotic was produced in the fermentation medium consisting of lactose 20 g, glucose 10 g, Pharmamedia 15 g, yeast extract 5 g, meat extract 10 g and CaCO3 2 g per liter of tap water.
Insights
A new antibiotic, DC-86-M, was discovered from soil bacteria, Streptomyces luteogriseus DO-86, in Japan. This novel compound shows potential for future antibiotic development.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Fermentation Technology
Background:
- The rise of antibiotic resistance necessitates the discovery of novel antimicrobial compounds.
- Soil microorganisms, particularly Streptomyces species, are a rich source of bioactive natural products.
Purpose of the Study:
- To isolate and characterize a novel antibiotic from a soil-derived microorganism.
- To identify and classify the producing bacterial strain.
Main Methods:
- Isolation of antibiotic DC-86-M from the culture broth of strain DO-86.
- Microbial identification using morphological, cultural, and physiological characteristics, including cell wall analysis.
- Fermentation optimization using a defined medium.
Main Results:
- A novel antibiotic, DC-86-M, was successfully isolated.
- The producing organism, strain DO-86, was identified as Streptomyces luteogriseus DO-86 based on its characteristics.
- Optimal fermentation conditions were established using a medium containing lactose, glucose, Pharmamedia, yeast extract, meat extract, and CaCO3.
Conclusions:
- Streptomyces luteogriseus DO-86 produces a novel antibiotic, DC-86-M.
- The characterized fermentation medium supports the production of this new antibiotic.
- Further investigation into DC-86-M's properties and potential applications is warranted.